Skip main navigation

Alison Macdonald, Antimicrobial Pharmacist

Alison Macdonald, Antimicrobial Pharmicist
5.6
Hi, my name is Alison MacDonald, I’m the antimicrobial pharmacist for NHS Highland in the north of Scotland. Today, I’m going to be talking about why we use antibiotic point prevalence surveys for local improvement within NHS Highland. Why conduct an antibiotic point prevalence survey? In NHS Highland, we have conducted these point prevalence surveys in a number of clinical areas over the last few years. At the moment, because there is no electronic prescribing record available in the hospital, the indication for antibiotic prescribing is recorded in the paper-based medical notes, and the drug therapy is prescribed on a paper drug chart. Both of these items are kept at ward level during the admission for the patient.
51
In order to obtain detailed information on antibiotic use and the indication for choice of therapy, we need to link the paper-based records from current inpatients. We use the point prevalence survey to describe the number and range of infections being treated at any one time in a clinical area. Planning your point prevalence survey. Past surveys covering the whole hospital were very time consuming for data collection purposes, including analysis and feedback of learning, so now we target discrete areas such as all the general medical wards, or all the orthopaedic wards, and target our feedback accordingly. We aim to conduct a survey in each clinical area every six months, with an annual survey in GP-led community hospitals. Who collects the data?
102.1
Depending on the area chosen and the availability of staff, data collection may be conducted by antimicrobial pharmacists, ward pharmacists, infection control nurses, or ward staff nurses. In the past, we’ve also had involvement of junior medical staff, but this is not consistently available. When using non-specialist staff to collect the data, this is useful if you’re distant from the site involved, but sometimes the data may be incomplete and require further clarification. Personally, when I collect the data, I tend to write more information on the sheet to remind me about the patient when I collate the data, and therefore can go back and speak to the infection specialist to discuss specific cases in more detail. Giving feedback.
149.2
We try to use existing clinical forum to deliver the results of the survey, as the attendance by the clinical teams at such a meeting is usually better than trying to arrange something specific. Face-to-face delivery is much more effective than email. Usually at these sessions, there’s a brief presentation of the results, drawing out a few key messages for improvement. Describing the results, including any changes since the last point prevalence survey can be useful, but bear in mind that surveys done at different time points in the year are not necessarily comparable.
186.7
When delivering the feedback, it’s important to concentrate on a few key messages for improvement, as this is an opportunity for education and learning for the clinical team that you’re delivering the feedback for. This is also an opportunity, if a change in guidelines is imminent or has recently been implemented, as new evidence for any change in therapy can be explained, allowing time for any questions. These sessions have also been used to discuss options for changing therapeutic choices, as the key consultants are often available. A recent example of this is our switch from piperacillin tazobactam to amoxicillin, gentamicin, and metronidazole combination, for the management of intra-abdominal sepsis in general surgery.
235.8
The face-to-face feedback session also allows questions from the guideline users, and this is vital to shape the guidelines, as these are written by experts, but for the general ward users. In addition, a formal report is submitted and discussed at the next meeting of the local antimicrobial management team, as it is important to share the results with a wider audience. In summary, the antibiotic point prevalence survey allows us to find real patient data, linking the indication for antibiotic therapy, and also the choice of therapy for that infection. It’s important to use anyone and everyone that you can to collect the data, bearing in mind the limitations, depending on the specialty or the profession that you use.
286.2
It’s important to share the results with the clinical team involved as soon as possible for the results to be meaningful. A two-way system for delivering feedback allows the users to discuss the issues that have been raised by the survey, and also ask questions of the guideline developers. We view these point prevalence surveys as excellent education opportunities with the front-line clinical teams, and will continue to conduct them on a regular basis.

In this video Alison Macdonald, Antimicrobial Pharmacist, describes her experience of the value of PPS in an individual hospital.

This article is from the free online

Antimicrobial Stewardship: Managing Antibiotic Resistance

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education